The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global NSAID Ophthalmic Drugs Market Research Report 2024

Global NSAID Ophthalmic Drugs Market Research Report 2024

Publishing Date : Aug, 2023

License Type :
 

Report Code : 1769147

No of Pages : 100

Ask Your Query

Synopsis
Non-steroidal anti-inflammatory drugs have been widely used in ophthalmology clinically due to the lack of adverse reactions such as increased intraocular pressure, secondary infection and cataracts caused by glucocorticoids

Global NSAID Ophthalmic Drugs market is projected to reach US$ 1812.3 million in 2029, increasing from US$ 930 million in 2022, with the CAGR of 10.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole NSAID Ophthalmic Drugs market research.

Key manufacturers engaged in the NSAID Ophthalmic Drugs industry include AbbVie, Bausch Health, Bayer, Dossa Pharmaceuticals, GlaxoSmithKline, Janssen Pharmaceuticals, Novartis, Pfizer and Sun Pharmaceutical Industries, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of NSAID Ophthalmic Drugs were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole NSAID Ophthalmic Drugs market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global NSAID Ophthalmic Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • AbbVie
  • Bausch Health
  • Bayer
  • Dossa Pharmaceuticals
  • GlaxoSmithKline
  • Janssen Pharmaceuticals
  • Novartis
  • Pfizer
  • Sun Pharmaceutical Industries
  • Senju Pharmaceutical
  • Sichuan Heyi Pharmaceutical
  • Shandong Haishan Pharmaceutical
  • Guangdong Zhongsheng Pharmaceutical
  • Hangzhou Minsheng Pharmaceutical
  • Cisen Pharmaceutical

Segment by Type

  • Pranoprofen Eye Drops
  • Diclofenac Sodium Eye Drops
  • Bromfenac Sodium Eye Drops
  • Other

Segment by Application

  • Hospital
  • Clinic
  • Other

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil,Turkey, GCC Countries)

The NSAID Ophthalmic Drugs report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 NSAID Ophthalmic Drugs Market Overview
1.1 Product Overview and Scope of NSAID Ophthalmic Drugs
1.2 NSAID Ophthalmic Drugs Segment by Type
1.2.1 Global NSAID Ophthalmic Drugs Market Value Comparison by Type (2023-2029)
1.2.2 Pranoprofen Eye Drops
1.2.3 Diclofenac Sodium Eye Drops
1.2.4 Bromfenac Sodium Eye Drops
1.2.5 Other
1.3 NSAID Ophthalmic Drugs Segment by Application
1.3.1 Global NSAID Ophthalmic Drugs Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global NSAID Ophthalmic Drugs Market Size Estimates and Forecasts
1.4.1 Global NSAID Ophthalmic Drugs Revenue 2018-2029
1.4.2 Global NSAID Ophthalmic Drugs Sales 2018-2029
1.4.3 Global NSAID Ophthalmic Drugs Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 NSAID Ophthalmic Drugs Market Competition by Manufacturers
2.1 Global NSAID Ophthalmic Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global NSAID Ophthalmic Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global NSAID Ophthalmic Drugs Average Price by Manufacturers (2018-2023)
2.4 Global NSAID Ophthalmic Drugs Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of NSAID Ophthalmic Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of NSAID Ophthalmic Drugs, Product Type & Application
2.7 NSAID Ophthalmic Drugs Market Competitive Situation and Trends
2.7.1 NSAID Ophthalmic Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest NSAID Ophthalmic Drugs Players Market Share by Revenue
2.7.3 Global NSAID Ophthalmic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 NSAID Ophthalmic Drugs Retrospective Market Scenario by Region
3.1 Global NSAID Ophthalmic Drugs Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global NSAID Ophthalmic Drugs Global NSAID Ophthalmic Drugs Sales by Region: 2018-2029
3.2.1 Global NSAID Ophthalmic Drugs Sales by Region: 2018-2023
3.2.2 Global NSAID Ophthalmic Drugs Sales by Region: 2024-2029
3.3 Global NSAID Ophthalmic Drugs Global NSAID Ophthalmic Drugs Revenue by Region: 2018-2029
3.3.1 Global NSAID Ophthalmic Drugs Revenue by Region: 2018-2023
3.3.2 Global NSAID Ophthalmic Drugs Revenue by Region: 2024-2029
3.4 North America NSAID Ophthalmic Drugs Market Facts & Figures by Country
3.4.1 North America NSAID Ophthalmic Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America NSAID Ophthalmic Drugs Sales by Country (2018-2029)
3.4.3 North America NSAID Ophthalmic Drugs Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe NSAID Ophthalmic Drugs Market Facts & Figures by Country
3.5.1 Europe NSAID Ophthalmic Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe NSAID Ophthalmic Drugs Sales by Country (2018-2029)
3.5.3 Europe NSAID Ophthalmic Drugs Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific NSAID Ophthalmic Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific NSAID Ophthalmic Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific NSAID Ophthalmic Drugs Sales by Country (2018-2029)
3.6.3 Asia Pacific NSAID Ophthalmic Drugs Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America NSAID Ophthalmic Drugs Market Facts & Figures by Country
3.7.1 Latin America NSAID Ophthalmic Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America NSAID Ophthalmic Drugs Sales by Country (2018-2029)
3.7.3 Latin America NSAID Ophthalmic Drugs Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa NSAID Ophthalmic Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa NSAID Ophthalmic Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa NSAID Ophthalmic Drugs Sales by Country (2018-2029)
3.8.3 Middle East and Africa NSAID Ophthalmic Drugs Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global NSAID Ophthalmic Drugs Sales by Type (2018-2029)
4.1.1 Global NSAID Ophthalmic Drugs Sales by Type (2018-2023)
4.1.2 Global NSAID Ophthalmic Drugs Sales by Type (2024-2029)
4.1.3 Global NSAID Ophthalmic Drugs Sales Market Share by Type (2018-2029)
4.2 Global NSAID Ophthalmic Drugs Revenue by Type (2018-2029)
4.2.1 Global NSAID Ophthalmic Drugs Revenue by Type (2018-2023)
4.2.2 Global NSAID Ophthalmic Drugs Revenue by Type (2024-2029)
4.2.3 Global NSAID Ophthalmic Drugs Revenue Market Share by Type (2018-2029)
4.3 Global NSAID Ophthalmic Drugs Price by Type (2018-2029)
5 Segment by Application
5.1 Global NSAID Ophthalmic Drugs Sales by Application (2018-2029)
5.1.1 Global NSAID Ophthalmic Drugs Sales by Application (2018-2023)
5.1.2 Global NSAID Ophthalmic Drugs Sales by Application (2024-2029)
5.1.3 Global NSAID Ophthalmic Drugs Sales Market Share by Application (2018-2029)
5.2 Global NSAID Ophthalmic Drugs Revenue by Application (2018-2029)
5.2.1 Global NSAID Ophthalmic Drugs Revenue by Application (2018-2023)
5.2.2 Global NSAID Ophthalmic Drugs Revenue by Application (2024-2029)
5.2.3 Global NSAID Ophthalmic Drugs Revenue Market Share by Application (2018-2029)
5.3 Global NSAID Ophthalmic Drugs Price by Application (2018-2029)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie NSAID Ophthalmic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AbbVie NSAID Ophthalmic Drugs Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Bausch Health
6.2.1 Bausch Health Corporation Information
6.2.2 Bausch Health Description and Business Overview
6.2.3 Bausch Health NSAID Ophthalmic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Bausch Health NSAID Ophthalmic Drugs Product Portfolio
6.2.5 Bausch Health Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer NSAID Ophthalmic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Bayer NSAID Ophthalmic Drugs Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Dossa Pharmaceuticals
6.4.1 Dossa Pharmaceuticals Corporation Information
6.4.2 Dossa Pharmaceuticals Description and Business Overview
6.4.3 Dossa Pharmaceuticals NSAID Ophthalmic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Dossa Pharmaceuticals NSAID Ophthalmic Drugs Product Portfolio
6.4.5 Dossa Pharmaceuticals Recent Developments/Updates
6.5 GlaxoSmithKline
6.5.1 GlaxoSmithKline Corporation Information
6.5.2 GlaxoSmithKline Description and Business Overview
6.5.3 GlaxoSmithKline NSAID Ophthalmic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 GlaxoSmithKline NSAID Ophthalmic Drugs Product Portfolio
6.5.5 GlaxoSmithKline Recent Developments/Updates
6.6 Janssen Pharmaceuticals
6.6.1 Janssen Pharmaceuticals Corporation Information
6.6.2 Janssen Pharmaceuticals Description and Business Overview
6.6.3 Janssen Pharmaceuticals NSAID Ophthalmic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Janssen Pharmaceuticals NSAID Ophthalmic Drugs Product Portfolio
6.6.5 Janssen Pharmaceuticals Recent Developments/Updates
6.7 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis NSAID Ophthalmic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Novartis NSAID Ophthalmic Drugs Product Portfolio
6.7.5 Novartis Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer NSAID Ophthalmic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Pfizer NSAID Ophthalmic Drugs Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Sun Pharmaceutical Industries
6.9.1 Sun Pharmaceutical Industries Corporation Information
6.9.2 Sun Pharmaceutical Industries Description and Business Overview
6.9.3 Sun Pharmaceutical Industries NSAID Ophthalmic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Sun Pharmaceutical Industries NSAID Ophthalmic Drugs Product Portfolio
6.9.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.10 Senju Pharmaceutical
6.10.1 Senju Pharmaceutical Corporation Information
6.10.2 Senju Pharmaceutical Description and Business Overview
6.10.3 Senju Pharmaceutical NSAID Ophthalmic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Senju Pharmaceutical NSAID Ophthalmic Drugs Product Portfolio
6.10.5 Senju Pharmaceutical Recent Developments/Updates
6.11 Sichuan Heyi Pharmaceutical
6.11.1 Sichuan Heyi Pharmaceutical Corporation Information
6.11.2 Sichuan Heyi Pharmaceutical NSAID Ophthalmic Drugs Description and Business Overview
6.11.3 Sichuan Heyi Pharmaceutical NSAID Ophthalmic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Sichuan Heyi Pharmaceutical NSAID Ophthalmic Drugs Product Portfolio
6.11.5 Sichuan Heyi Pharmaceutical Recent Developments/Updates
6.12 Shandong Haishan Pharmaceutical
6.12.1 Shandong Haishan Pharmaceutical Corporation Information
6.12.2 Shandong Haishan Pharmaceutical NSAID Ophthalmic Drugs Description and Business Overview
6.12.3 Shandong Haishan Pharmaceutical NSAID Ophthalmic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Shandong Haishan Pharmaceutical NSAID Ophthalmic Drugs Product Portfolio
6.12.5 Shandong Haishan Pharmaceutical Recent Developments/Updates
6.13 Guangdong Zhongsheng Pharmaceutical
6.13.1 Guangdong Zhongsheng Pharmaceutical Corporation Information
6.13.2 Guangdong Zhongsheng Pharmaceutical NSAID Ophthalmic Drugs Description and Business Overview
6.13.3 Guangdong Zhongsheng Pharmaceutical NSAID Ophthalmic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Guangdong Zhongsheng Pharmaceutical NSAID Ophthalmic Drugs Product Portfolio
6.13.5 Guangdong Zhongsheng Pharmaceutical Recent Developments/Updates
6.14 Hangzhou Minsheng Pharmaceutical
6.14.1 Hangzhou Minsheng Pharmaceutical Corporation Information
6.14.2 Hangzhou Minsheng Pharmaceutical NSAID Ophthalmic Drugs Description and Business Overview
6.14.3 Hangzhou Minsheng Pharmaceutical NSAID Ophthalmic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Hangzhou Minsheng Pharmaceutical NSAID Ophthalmic Drugs Product Portfolio
6.14.5 Hangzhou Minsheng Pharmaceutical Recent Developments/Updates
6.15 Cisen Pharmaceutical
6.15.1 Cisen Pharmaceutical Corporation Information
6.15.2 Cisen Pharmaceutical NSAID Ophthalmic Drugs Description and Business Overview
6.15.3 Cisen Pharmaceutical NSAID Ophthalmic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Cisen Pharmaceutical NSAID Ophthalmic Drugs Product Portfolio
6.15.5 Cisen Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 NSAID Ophthalmic Drugs Industry Chain Analysis
7.2 NSAID Ophthalmic Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 NSAID Ophthalmic Drugs Production Mode & Process
7.4 NSAID Ophthalmic Drugs Sales and Marketing
7.4.1 NSAID Ophthalmic Drugs Sales Channels
7.4.2 NSAID Ophthalmic Drugs Distributors
7.5 NSAID Ophthalmic Drugs Customers
8 NSAID Ophthalmic Drugs Market Dynamics
8.1 NSAID Ophthalmic Drugs Industry Trends
8.2 NSAID Ophthalmic Drugs Market Drivers
8.3 NSAID Ophthalmic Drugs Market Challenges
8.4 NSAID Ophthalmic Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock